biotx.ai announcing discovery of Covid-19 treatment by using revolutionary genetic predictive models

biotx.ai announcing discovery of Covid-19 treatment by using revolutionary genetic predictive models

ID: 628916

(firmenpresse) - Potsdam, Germany: biotx.ai, a Potsdam, Germany based genetic analytics start-up today announced the discovery of the direct impacts of cyclin-dependent kinase 6 (CDK6) and neutrophils on patients with severe COVID-19.

biotx.ai’s scientists simulated the severe COVID-19 phenotype in genomic data with its proprietary AI prediction platform in order to find gene variants that influence the disease outcome.

“Currently investigated immune blockers had only weak signals in our simulation whereas CDK6 inhibitors showed strong causal effects to prevent lung thromboinflammation, the main deadly outcome of severe COVID-19. I am very proud of the team. Our aim is to contribute to better and faster treatment of patients during this global pandemic using novel statistical tools for genomics.” said Dr. Joern Klinger, biotx.ai CEO and co-founder.

Patients can now expect a much faster availability of COVID-19 treatments by utilizing three repurposed and already regulatory approved drugs, which were developed by three global pharmaceutical companies to medicate breast cancer successfully.

biotx.ai will continue to work with research organizations across the globe using the unique biotx.ai platform and applying its library, drug target linkage and diagnostics solutions.



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Stress-related absence up 64% in 2020 as COVID-19 exacerbates the UK’s mental health crisis NHS Digital award accreditation for Isosec Virtual Smartcards
Bereitgestellt von Benutzer: RealWire
Datum: 02.02.2021 - 13:31 Uhr
Sprache: Deutsch
News-ID 628916
Anzahl Zeichen: 1343

contact information:
Contact person: Courtney Dean
Town:

Lincoln


Phone: 01522 883 640

Kategorie:

Healthcare & Medical


Typ of Press Release: please
type of sending: don't

Diese Pressemitteilung wurde bisher 353 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"biotx.ai announcing discovery of Covid-19 treatment by using revolutionary genetic predictive models"
steht unter der journalistisch-redaktionellen Verantwortung von

RealWire (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

neXat expands further East with KT SAT partnership ...

17 May 2023 – neXat has entered a partnership with KT SAT to offer the South Korean satellite operator a full suite of managed services and gain access to its coverage in Asia. KT SAT – a subsidiary of KT Corporation and one of South Korea’ ...

Alle Meldungen von RealWire



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z